The genome research company, which includes IDG among its investor base, has raised more than $70m in total.

Origene Technologies, a US-based human genome research company backed by media and data company International Data Group (IDG), has raised $17m of a $32m equity round, according to a regulatory filing.

Origene oversees a collection of DNA and RNA research samples, as well as human tissues, and protein microarray products and services. It has raised more than $70m in funding since it was founded, according to press releases and regulatory filings.

IDG-Accel, the joint venture between IDG and venture firm…